SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-18-008151
Filing Date
2018-04-13
Accepted
2018-04-13 16:11:36
Documents
3
Period of Report
2018-06-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A mack-pre14a_20180612.htm PRE 14A 1603544
2 GRAPHIC g2018041314225179711492.jpg GRAPHIC 57365
3 GRAPHIC g2018041314225183111493.jpg GRAPHIC 50353
  Complete submission text file 0001564590-18-008151.txt   1753212
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35409 | Film No.: 18754429
SIC: 2834 Pharmaceutical Preparations